Center for Translational Medicine Receives $1.7 Million Gift in Kind
February 13, 2015
Gift of software will benefit students in the School’s Master of Science in Pharmacometrics program and aid researchers in the Center for Translational Medicine.
February 13, 2015
Gift of software will benefit students in the School’s Master of Science in Pharmacometrics program and aid researchers in the Center for Translational Medicine.
January 23, 2015
Concerns surrounding the implementation of the new Drug Quality and Security Act are highlighted at event co-sponsored by the University of Maryland Schools of Pharmacy and Law and the Food and Drug Law Institute.
January 12, 2015
Grants will support the development of quantitative pharmacometric models to advance the evaluation of generic drugs.
September 10, 2014
Collaboration with University of New Mexico College of Pharmacy will employ expertise of the School’s Mass Spectrometry Center.
September 9, 2014
Partnership led by the School of Pharmacy will increase the scope and impact of Alzheimer’s disease and healthy aging research.
August 29, 2014
Four teams compete for $75,000 award to fund new initiatives to advance the mission, research, and reputation of the School’s Department of Pharmaceutical Health Services Research.
July 14, 2014
Leaders in academia, government, and industry highlight latest research and advances in the field.
June 30, 2014
Researchers from academia, government, and industry examine benefits and new methods associated with emerging technology.
May 27, 2014
Michele Suit honored for exceptional leadership skills during a time of transition in the School’s Department of Pharmaceutical Health Services Research.
April 22, 2014
Family and friends gather to remember Dr. Peter Lamy and celebrate his work to improve the quality of medication use in the elderly.
April 16, 2014
Researchers from academia, government, and industry examine current challenges surrounding mass spectrometry as a drug development tool, including its status of adoption by industry and potential regulatory implications.
March 4, 2014
Improper use of and non-adherence to evidence-based medications remain leading causes of poor outcomes and increased health care costs for many Medicare beneficiaries with diabetes, heart failure, and COPD.